R. Schreiber, K. Crane, and J. Patel, “Efficacy and Tolerability of Tazarotene Foam 0.1% Across Age, Gender, and Race: An Integrated Review of Two Phase III Trials”, J of Skin, vol. 1, no. 3.1, p. s50, Oct. 2017.